Regulatory News
April 5, 2018 / 12:11 PM / a year ago

BRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA Submission

1 Min Read

April 5 (Reuters) - Aradigm Corp:

* ARADIGM ANNOUNCES THE EMA HAS COMPLETED ITS VALIDATION OF THE MAA SUBMISSION

* OPINION OF COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) FOR LINHALIQ EXPECTED WITHIN 210 DAYS​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below